(MENAFN- ForPressRelease) 24th March 2023: With the ever-growing popularity of Korean dramas across the country, India's leading youth entertainment channel – Zing is ever ready to meet the entertainment needs of its Gen-Z audience with fresh and young content. This month, it brings you the medical K-Drama series 'Doctor Stranger' for its viewers. This show features leading stars from the Korean industry in pivotal roles, and is all set to air on Zing from 27th March 2023 in the channel's Hallyu Time Slot from 6pm to 7pm.
Doctor Stranger follows the story of a talented neurosurgeon, Park Hoon, who falls in love with a mysterious woman, Song Jae Hee. As the story progresses, their complicated past and love for each other is tested as they navigate various challenges. Park Hoon also finds himself drawn to Oh Soo Hyun, who is the daughter of the hospital director. He is torn between his feelings for Oh Soo Hyun and his loyalty to his childhood sweetheart, Song Jae Hee, who like him was also a defector from North Korea. This drama is the first ever medical drama to air on the channel and will guarantee to keep the audiences on the edge of their seats.
Talking about the show, Arghya Roy Chowdhury, Chief Channel Officer – Zing shared, "We are so happy to receive the immense love & support from our audience for all the shows that we air on Zing. The overwhelming response only keeps us motivated to bring the best of K-dramas for our viewers. Doctor Stranger is another engaging drama that will captivate the audiences with its compelling storylines and endearing characters, and exclusive watch for all our Gen-Z audience. We hope they will cherish watching the same and we will try our best to come up with more such quality content in the future as well."
User :- Hinjal Veera
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.